8 Coupons
-
Special Offer
-
30% off
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
..
cancer patients� lives are being put at risk because savage tory cuts to the nhs are delaying the start of their treatment by 18 months. .